Our business model is to apply deep Intellectual Property commercialisation expertise to building a portfolio of successful companies through:
The Group earns its equity and revenue by helping businesses to grow in value, providing downstream attractive returns for Frontier IP’s shareholders and stakeholders. Equity stakes are earned through providing practical support ahead of arranging capital.
Our team works with a range of universities and sources of deal flow and continues to develop new sources of IP from both formal and informal relationships.
• Investment firm focused on commercialisation of IPs
• Provides services to university and research organisations to brink products to market
• Takes equity stakes in spin-out companies
The first human trials have started in the US while Russia and China are ramping up developments too
